Suppr超能文献

在犬氟烷麻醉期间,维拉帕米或地尔硫䓬与普萘洛尔联合应用时的心血管及肾上腺素能作用。

The cardiovascular and adrenergic actions of verapamil or diltiazem in combination with propranolol during halothane anesthesia in the dog.

作者信息

Kapur P A, Matarazzo D A, Fung D M, Sullivan K B

出版信息

Anesthesiology. 1987 Feb;66(2):122-9. doi: 10.1097/00000542-198702000-00003.

Abstract

Continuous infusions of verapamil and diltiazem were established in halothane-anesthetized dogs (1.15-1.35% end tidal concentration) with or without a concomitant propranolol infusion to investigate changes: in cardiovascular function, in reflex activation as reflected in circulating catecholamine levels, and in the chronotropic response to the exogenously administered beta agonist, isoproterenol. Verapamil plasma levels of approximately 100 and 250 ng X ml-1, diltiazem plasma levels of approximately 140 and 325 ng X ml-1, and propranolol levels of approximately 70 ng X ml-1 were tolerated individually in the presence of halothane, although atrioventricular conduction was prolonged in the verapamil and diltiazem groups. Catecholamine levels were increased in the high verapamil group. However, when propranolol was combined with the lower levels of verapamil or diltiazem, the result was decreased heart rate, blood pressure, left ventricular maximum rate of tension development (dP/dt), and cardiac index with increased systemic vascular resistance. When the attempt was made to proceed to the increased plasma levels of verapamil or diltiazem in the presence of propranolol, 6/6 animals in the verapamil-propranolol group and 4/6 animals in the diltiazem-propranolol group were unable to maintain a mean arterial blood pressure of greater than 50 mmHg, and many developed 2 degrees or higher heart block.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在氟烷麻醉的犬(呼气末浓度为1.15 - 1.35%)中建立维拉帕米和地尔硫䓬的持续输注,无论是否同时输注普萘洛尔,以研究心血管功能的变化、循环儿茶酚胺水平所反映的反射激活变化,以及对外源性给予的β激动剂异丙肾上腺素的变时反应变化。在氟烷存在的情况下,维拉帕米血浆水平约为100和250 ng·ml⁻¹、地尔硫䓬血浆水平约为140和325 ng·ml⁻¹、普萘洛尔水平约为70 ng·ml⁻¹时,个体均能耐受,尽管维拉帕米组和地尔硫䓬组的房室传导延长。高剂量维拉帕米组的儿茶酚胺水平升高。然而,当普萘洛尔与较低剂量的维拉帕米或地尔硫䓬联合使用时,结果是心率、血压、左心室最大张力发展速率(dP/dt)和心脏指数降低,全身血管阻力增加。当试图在普萘洛尔存在的情况下提高维拉帕米或地尔硫䓬的血浆水平时,维拉帕米 - 普萘洛尔组的6/6只动物和地尔硫䓬 - 普萘洛尔组的4/6只动物无法维持平均动脉血压大于50 mmHg,许多动物出现二度或更高程度的心脏传导阻滞。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验